Related references
Note: Only part of the references are listed.A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis
Atsushi Hata et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Advances in Prevention and Surveillance of Cutaneous Malignancies
Megan H. Trager et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Epidemiology and Risk Factors of Melanoma
Stephanie Carr et al.
SURGICAL CLINICS OF NORTH AMERICA (2020)
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma
Yasuhiro Fujisawa et al.
CANCER MEDICINE (2019)
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis
Kiyoko Takane et al.
Oncotarget (2018)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Goran Micevic et al.
CLINICAL EPIGENETICS (2017)
Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma
Brittani Seynnaeve et al.
SCIENTIFIC REPORTS (2017)
Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer
Takuya Nakagawa et al.
CANCER LETTERS (2017)
Racial differences in six major subtypes of melanoma: descriptive epidemiology
Yu Wang et al.
BMC CANCER (2016)
Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
Katja Harbst et al.
CANCER RESEARCH (2016)
Targeting the cancer epigenome for therapy
Peter A. Jones et al.
NATURE REVIEWS GENETICS (2016)
Extracellular Release of Annexin A2 is Enhanced upon Oxidative Stress Response via the p38 MAPK Pathway after Low-Dose X-Ray Irradiation
Kazuko Kita et al.
RADIATION RESEARCH (2016)
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes
Martin Lauss et al.
BMC MEDICAL GENOMICS (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients
Kaori Sakaizawa et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2015)
KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma
Christina Dahl et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
The Genetic Evolution of Melanoma from Precursor Lesions
A. Hunter Shain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2)
Koshiki Mino et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2014)
NRAS mutations in primary and metastatic melanomas of Japanese patients
Hisashi Uhara et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy
Linda Gao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features
Nancy E. Thomas et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
Matthew T. Seymour et al.
LANCET ONCOLOGY (2013)
A DNA hypermethylation module for the stem/progenitor cell signature of cancer
Hariharan Easwaran et al.
GENOME RESEARCH (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Classification of Epstein-Barr Virus-Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes
Keisuke Matsusaka et al.
CANCER RESEARCH (2011)
Activation of Bmp2-Smad1 Signal and Its Regulation by Coordinated Alteration of H3K27 Trimethylation in Ras-Induced Senescence
Atsushi Kaneda et al.
PLOS GENETICS (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Three DNA Methylation Epigenotypes in Human Colorectal Cancer
Koichi Yagi et al.
CLINICAL CANCER RESEARCH (2010)
Melanoma epidemiology and trends
Claus Garbe et al.
CLINICS IN DERMATOLOGY (2009)
Genome-wide screen of promoter methylation identifies novel markers in melanoma
Yasuo Koga et al.
GENOME RESEARCH (2009)
CpG island methylation profiling in human melanoma cell lines
Carmen S. Tellez et al.
MELANOMA RESEARCH (2009)
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Manching Ku et al.
PLOS GENETICS (2008)
Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas
Yoshimasa Nobeyama et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Epigenetic stem cell signature in cancer
Martin Widschwendter et al.
NATURE GENETICS (2007)
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
Michael Weber et al.
NATURE GENETICS (2007)
The cancer epigenome - components and functional correlates
Angela H. Ting et al.
GENES & DEVELOPMENT (2006)
Epigenetic silencing of novel tumor suppressors in malignant melanoma
Viswanathan Muthusamy et al.
CANCER RESEARCH (2006)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epigenetic silencing of the PTEN gene in melanoma
Alireza Mirmohammadsadegh et al.
CANCER RESEARCH (2006)
Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas
Junichi Furuta et al.
CANCER RESEARCH (2006)
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma
N Sato et al.
ONCOGENE (2005)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion
SD Konduri et al.
ONCOGENE (2001)